Understanding the Chinese clinical practice guideline on the management of ulcerative colitis(2023,Xi'an)——goals of treatment
With the deepening research on ulcerative colitis(UC)in China and the continuous accumulation of clinical evi-dence,new diagnostic assessment techniques,therapeutic drugs,and treatment plans have been rapidly updated and iterated.The In-flammatory Bowel Disease Group of Chinese Society of Gastroenterology of Chinese Medical Association has updated the"Chinese con-sensus on diagnosis and treatment of inflammatory bowel disease(2018,Beijing)",and released the"Chinese clinical practice guide-line on the management of ulcerative colitis(2023,Xi'an)",which re-sorted out treatment methods,strategies and concepts,and incor-porated new treatment goals into the Guideline.This article aims to provide a detailed interpretation of this progress,in order to offer guidance and reference for clinical practice.
NETL
NSTL
万方数据
